Plasma Fractionation: Industry Overview, Application, and Latest Trend in the Market

Plasma present in a human’s body carries all the essential nutrients, hormones, and proteins across the body, except enzymes, water, and salt. Sound interesting right? But do you know what is plasma fractionation? If NO, then no need to worry because in this blog we are going to discuss more about plasma fractionation. So, let’s begin with a quick snapshot of the Plasma Fractionation first.

A Brief Introduction About the Global Plasma Fractionation Market

Any process in which a mixture of liquids, gases, or solids is separated from its components is called ‘Fractionation. ‘So, plasma fractionation is simply the separation of several components of blood, many of which are highly therapeutic. In simple words, it is a biomedical procedure that involves the separation and purification of blood plasma into its individual components including protein and other biomolecules. The process includes several steps including – collection, separation, purification, sterilization, and formulation, ensuring that the final products meet strict safety and quality standards for clinical uses.

Additionally, it is estimated that the Global Plasma Fractionation Market is expected to grow at a CAGR of around 7.1% from 2024 to 2030. The growth of the plasma fractionation market is rising due to the increasing demand for plasma-derive therapy across the world, owing to the commonness of rare disorders in the global population.

How many Applications of Plasma Fractionation are There?

On the basis of applications, the Global Plasma Fractionation Market is classified into the following segments:

• Neurology
• Immunology
• Hematology
• Critical Care
• Pulmonology
• Rheumatology
• Others (Oncology, Pediatrics, etc.)

Out of these, the Neurology segment held a prominent share of the plasma fractionation market, owing to the rapid & effective response offered by Intravenous immunoglobulins, in comparison to oral immuno-suppressants and steroids. Moreover, witnessing, the mortality rate, the requirement for effective plasma therapy has improved, as a result, companies are focusing on the R&D of plasma-fractionated drugs required to treat neurological disorders.

Thus, with the introduction of innovative therapies offering better results, healthcare professionals would be inclined towards plasma fractionated drugs for the treatment of neurological disorders.

What is the Latest Trend in the Global Plasma Fractionation Market?

The latest trend in the plasma fractionation market is the expansion of plasma fractionation plants. The rising positive outcomes of plasma-derived drugs for chronic, autoimmune, and other diseases have raised the demand for plasma fractionation products in the market. Moreover, the increasing demand for plasma fractionation products has prompted global plasma fractionation manufacturers in the industry including Grifols, and Takeda Pharmaceuticals, to embark on a trend of establishing new manufacturing facilities across the globe.

In addition, the current trend in the plasma fractionation industry is the expansion of plasma fractionation plant. The increasing positive outcome of plasma-derived drugs chronic, autoimmune, and other diseases has raised the demand for plasma fractionation products 

Summing Up

Plasma fractionation is critical to the treatment of several life-threatening diseases. Owing to the rising population of immunoglobulins and albumins, combined with the attempts to reduce plasma manufacturing costs, it is believed that the plasma fractionation market will experience notable growth in the forecasted period. Moreover, driven by the constant technological innovations, this industry is expected to witness remarkable market growth.